Novanta (NOVT) to Release Earnings on Tuesday

Novanta (NASDAQ:NOVT) will be releasing its earnings data before the market opens on Tuesday, May 7th. Analysts expect Novanta to post earnings of $0.57 per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Novanta (NASDAQ:NOVT) last released its quarterly earnings data on Wednesday, February 28th. The technology company reported $0.63 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.63. Novanta had a net margin of 8.27% and a return on equity of 17.15%. The company had revenue of $211.60 million during the quarter, compared to analysts’ expectations of $210.90 million. During the same quarter in the previous year, the company earned $0.75 earnings per share. The firm’s revenue for the quarter was down 3.1% on a year-over-year basis. On average, analysts expect Novanta to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Novanta Trading Up 0.4 %

NOVT stock opened at $160.03 on Tuesday. Novanta has a 52-week low of $111.20 and a 52-week high of $187.60. The company has a quick ratio of 1.91, a current ratio of 2.98 and a debt-to-equity ratio of 0.52. The firm has a market cap of $5.74 billion, a P/E ratio of 78.83 and a beta of 1.33. The company’s 50-day simple moving average is $166.85 and its 200-day simple moving average is $156.78.

Insider Buying and Selling

In other news, CEO Matthijs Glastra sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $172.00, for a total value of $860,000.00. Following the completion of the sale, the chief executive officer now directly owns 24,572 shares in the company, valued at $4,226,384. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Matthijs Glastra sold 5,000 shares of the stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $172.00, for a total transaction of $860,000.00. Following the transaction, the chief executive officer now owns 24,572 shares in the company, valued at approximately $4,226,384. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Robert Buckley sold 1,500 shares of Novanta stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $160.23, for a total transaction of $240,345.00. Following the completion of the sale, the chief financial officer now directly owns 120,159 shares in the company, valued at approximately $19,253,076.57. The disclosure for this sale can be found here. In the last 90 days, insiders sold 11,000 shares of company stock valued at $1,846,160. 1.20% of the stock is owned by company insiders.

About Novanta

Novanta Inc, together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.